Candriam Equities L Biotechnology C - Thesaurierung/  LU0108459040  /

Fonds
NAV9/6/2024 Chg.-9.8700 Type of yield Investment Focus Investment company
905.8300USD -1.08% reinvestment Equity Candriam 

Funds documents

Date Document Year Language Filesize
9/9/2024 Public WebStation Live Factsheet 2024 English -
6/30/2024 Semi-annual report 2024 German -
6/30/2024 Semi-annual report 2024 English -
6/3/2024 Prospectus 2024 English 3,663.84 KB
6/3/2024 Prospectus 2024 German 5,520.88 KB
3/1/2024 PRIIP Key Information Document 2024 German 268.16 KB
12/31/2023 Account statment 2023 English 5,416.37 KB
12/31/2023 Account statment 2023 German 4,732.66 KB
9/11/2023 PRIIP Key Information Document 2023 English 217.63 KB
12/1/2022 Key Investor Information 2022 German 367.75 KB